Tag: Sonelokimab

#VisualAbstract: Sonelokimab showed significant clinical benefit over placebo in patients with plaque psoriasis

byConstance Wu

May 12, 2021

1. At 12 weeks, the proportion of patients with an IGA score of 0 or 1 was significantly greater in ...

Quick Take: Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent)

Sonelokimab 120 mg or less showed significant clinical benefit over placebo in patients with plaque psoriasis

byNeel Mistryand1 others

May 5, 2021

1. At 12 weeks, the proportion of patients with an IGA score of 0 or 1 was significantly greater in ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result